The following post comes from Austin Shaffer, a 2L at Scalia Law and a Research Assistant at CPIP. By Austin Shaffer In their new paper, Distorted Drug Patents, CPIP Senior […]
[Archived Post] The Drug Innovation Paradox: Matching Incentives to Market Realities
The hardest things are often the most important things. That’s one of the implicit justifications for the intellectual property system. If we want people to do the hard and important […]
[Archived Post] The European Union Extends Copyright in Design—and Critics Balk (Yet Again)
By Bhamati Viswanathan The European Union recently decided to support the productive labors of designers by extending legal protections of their works in all areas of copyright, design, and patent […]